mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.3 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |